(Press-News.org) We age in part thanks to "friendly fire" from the immune system -- inflammation and chemically active molecules called reactive oxygen species that help fight infection, but also wreak molecular havoc over time, contributing to frailty, disability and disease. The CD33rSiglec family of proteins are known to help protect our cells from becoming inflammatory collateral damage, prompting researchers at the University of California, San Diego School of Medicine to ask whether CD33rSiglecs might help mammals live longer, too.
In a study published April 7 by eLife, the team reports a correlation between CD33rSIGLEC gene copy number and maximum lifespan across 14 mammalian species. In addition, they found that mice lacking one CD33rSIGLEC gene copy don't live as long as normal mice, have higher levels of reactive oxygen species and experience more molecular damage.
"Though not quite definitive, this finding is provocative. As far as we know, it's the first time lifespan has been correlated with simple gene copy number," said Ajit Varki, MD, Distinguished Professor of Medicine and Cellular and Molecular Medicine and member of the UC San Diego Moores Cancer Center. "Since people also vary in number of CD33rSIGLEC gene copies, it will be interesting to see if these genes influence variations in human lifespan as they do in mice."
Varki led the study, along with Pascal Gagneux, PhD, associate professor of pathology.
The CD33rSIGLEC genes encode siglec receptors that bind sialic acids -- sugar molecules found on many cells. These siglec receptors stick out like antennae on the outer surface of immune cells, probing the surface of other "self" cells in the body. When sialic acids bind siglec receptors, they transmit the message to the inside of the cell. This signal relay puts a brake on immune cell activation. In this way, the CD33rSiglec receptors help dampen chronic inflammation and reactive oxygen species in the body.
Different mammal species carry different numbers of the CD33rSIGLEC genes in their genomes. In this study, Varki, Gagneux and colleagues surveyed 14 different mammalian genomes, including those of elephants, dogs, monkeys and humans, and found that CD33rSIGLEC gene number correlates with maximum lifespan. In other words, species with more copies tend to live longer, even when the researchers controlled for other factors, such as body mass, adjacent genes and shared evolutionary history.
To dig deeper, Varki, Gagneux and team turned to a mouse model. They discovered that mice that were missing one CD33rSIGLEC gene and experienced inflammation early in life showed signs of accelerated aging (gray hair, disorientation, thin skin), had higher levels of reactive oxygen species and did not live as long as normal mice.
"The higher CD33rSIGLEC gene number can be thought of as an improved maintenance system that co-evolved in mammals to buffer against the effects of many infectious episodes fought off by the immune system of long-lived mammals," said Gagneux.
INFORMATION:
Study co-authors include Flavio Schwarz, Oliver M. T. Pearce, Xiaoxia Wang, Annie N. Samraj, Heinz Läubli, Javier O. Garcia, Andrea Garcia-Bingman, Patrick Secrest, Casey E. Romanoski, Charles Heyser, Christopher K. Glass, and Nissi Varki, UC San Diego; Hongqiao Lin, Xiaoming Fu and Stanley L. Hazen, Cleveland Clinic Lerner Research Institute.
This research was funded, in part, by the National Institutes of Health (grants P01HL107150, P01HL076491 and RO11065732), Ellison Foundation, Mathers Foundation of New York, Novartis Foundation for medical-biological research, Cancer Research Institute and AB SCIEX.
Viagra and other related drugs are not a universal 'cure-all' for impotence, according to a new study from The University of Manchester and NatCen Social Research.
Drugs, clinically known as oral phosphodiesterase type 5 inhibitors (PDE5i), have become the first-line medical treatment option for sufferers of erectile dysfunction (ED) - also known as impotence - since entering the UK market in 1998.
An abundance of studies has demonstrated the effectiveness of such drugs. But researchers at The University of Manchester, who have studied the responses of more than 2,600 ...
Cancer researchers from the University of Zurich have identified a key signaling pathway in B-cell lymphoma, a malignant type of blood cancer. They demonstrate that the signaling pathway can be blocked using compounds that are already in clinical development. This finding might be extremely important for the diagnosis, prognosis and treatment of this disease in the future.
Diffuse large B-cell lymphoma (DLBCL) is a blood cancer and the most common malignant condition of the lymphatic system. Although DLBCL is always fatal if left untreated, the cure rate after chemo-therapy ...
Improving the quality and quantity of U.S. military members' sleep following deployment could help reduce other health problems, including depression and post-traumatic stress disorder, according to a new RAND Corporation study.
However, a lack of consistent and transparent sleep-related policies may impede efforts to promote sleep health among service members, researchers say.
"The U.S. military has shifted from combat operations in Iraq and Afghanistan toward helping service members and veterans reintegrate into noncombat roles," said Wendy Troxel, co-leader of the ...
BOULDER -The Sun undergoes a type of seasonal variability with its activity waxing and waning over the course of nearly two years, according to a new study by a team of researchers led by the National Center for Atmospheric Research (NCAR). This behavior affects the peaks and valleys in the approximately 11-year solar cycle, sometimes amplifying and sometimes weakening the solar storms that can buffet Earth's atmosphere.
The quasi-annual variations appear to be driven by changes in the bands of strong magnetic fields in each solar hemisphere. These bands also help shape ...
Human cytomegalovirus (HCMV) is an extremely common virus, which as other members of the herpes virus family causes life-long infections in humans. Most individuals are exposed to HCMV during childhood, yet symptoms can be easily fought off by a healthy immune system. However, infections can be life-threatening for individuals with defective immunity, for instance newborn babies, people with AIDS, or those taking immunosuppressive drugs following organ transplantation. Scientists at École Polytechnique Fe?de?rale de Lausanne (EPFL) have discovered the molecular switch ...
In the world of the tiny zebrafish, the predatory red tiger oscar is the stuff of nightmares. And while the species has no natural reason to fear robots, researchers at the NYU Polytechnic School of Engineering have published the first study showing that, in a side-by-side comparison, a robotic predator can spook zebrafish just as well as the real thing. Their results may help advance understanding of fear and anxiety in animal populations, including humans.
The study, along with an image of the strikingly lifelike robotic model, is the cover story of the forthcoming ...
Catheter-related bloodstream infection is the most prevalent and severe complication for patients who receive parenteral nutrition therapy at home. A new study by researchers at Aalborg University in Denmark examined whether environmental factors have any influence on the amount of time before a first infection.
The study published today in the OnlineFirst version of the Journal of Parenteral and Enteral Nutrition (JPEN), the research journal of the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.), focused on tunneled vascular access devices and peripherally ...
A new study supports human milk as the optimal first food for babies, but the study raises questions about whether breast milk protects children from becoming obese.
The Cincinnati Children's Medical Center review of more than 80 relevant breastfeeding studies that were conducted over a period of at least 20 years is published in Current Obesity Reports.
"The best observational evidence up to now suggests that exclusively breastfeeding, or at least breastfeeding for a longer time, is associated with a 10 to 20 percent reduction in obesity prevalence in childhood," says ...
1. Weight Watchers and Jenny Craig come out on top among commercial weight loss programs
Note: Sound bites, b-roll footage, and image available. Satellite coordinates and feed times are below.
Physicians looking for an effective commercial weight-loss program for their overweight and obese patients may want to recommend Weight Watchers or Jenny Craig. According to an updated evidence review of 11 commercial weight-loss programs, only Weight Watchers and Jenny Craig showed evidence for effective long-term weight loss. The review is published in Annals of Internal Medicine. ...
In a bid to help physicians guide obese and overweight patients who want to try a commercial weight-loss program, a team of Johns Hopkins researchers reviewed 4,200 studies for solid evidence of their effectiveness but concluded only a few dozen of the studies met the scientific gold standard of reliability.
In a review of the best research available through late 2014, the results suggest that only a few programs have shown that their users lose more weight than those not using them. The findings are published in the April 6 Annals of Internal Medicine, along with a ...
